VNRX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide...

Stats
Today's Volume	245 612
Average Volume	118 125
Market Cap	50.55M
EPS	$-0.110 ( 2024-03-26 )
Next earnings date	( $-0.110 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.230
ATR14	$0.00500 (0.79%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Retter Andrew	Sell	0	No securities are beneficially owned
2024-01-24	Forterre Gael	Buy	25 925	Common Stock
2024-01-24	Michel Gaetan	Buy	42 925	Common Stock
2024-01-24	Innes Guy Archibald	Buy	8 500	Common Stock
2024-01-24	Micallef Jacob Vincent	Buy	23 375	Common Stock

INSIDER POWER
45.05
Last 100 transactions
Buy: 2 825 718 \| Sell: 1 112 036

Volume Correlation

Long: -0.29 (neutral)

Short: -0.81 (strong negative)

Signal:(63.077) Neutral

VolitionRX Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

VolitionRX Ltd Correlation - Currency/Commodity

0.09
( neutral )

0.40
( neutral )

0.00
( neutral )

0.17
( neutral )

0.00
( neutral )

-0.14
( neutral )

VolitionRX Ltd Financials

Annual	2023
Revenue:	$775 302
Gross Profit:	$-636 325 (-82.07 %)
EPS:	$-0.500

Q4	2023
Revenue:	$243 973
Gross Profit:	$-118 942 (-48.75 %)
EPS:	$-0.110

Q3	2023
Revenue:	$165 211
Gross Profit:	$-197 256 (-119.40 %)
EPS:	$-0.110

Q2	2023
Revenue:	$216 310
Gross Profit:	$-135 358 (-62.58 %)
EPS:	$-0.140

Financial Reports:

No articles found.

VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.